<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129623">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02146976</url>
  </required_header>
  <id_info>
    <org_study_id>20140522</org_study_id>
    <nct_id>NCT02146976</nct_id>
  </id_info>
  <brief_title>Postoperative Sleep Quality of Patients Anesthesia With Propofol or Sevoflurane Undergoing Thyroidectomy</brief_title>
  <official_title>Postoperative Sleep Quality of Patients Anesthesia With Target-controlled Infusion (Propofol) or Inhaled Anaesthetic (Sevoflurane) Undergoing Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University, China</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators designed a study to determine whether target-controlled infusion
      (Propofol) or Inhaled anaesthetic (Sevoflurane)  would provide same postoperative sleep
      quality in patients undergoing thyroidectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators designed a study to determine whether target-controlled infusion
      (Propofol) or Inhaled anaesthetic (Sevoflurane) would provide same postoperative sleep
      quality in patients undergoing thyroidectomy.The bispectral index score (BIS) was monitored
      during the operation and the first postoperative night.The sleep quality will be test with
      Pittsburgh sleep quality index (PSQI) and Postoperative sleep quality index of China Medical
      University (PSQI-CMU)
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The Change of postoperative sleep quality</measure>
    <time_frame>preoperation, first and second postoperative night</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>All patients underwent baseline Pittsburgh sleep quality index (PSQI) were assessed one day before operation, postoperative first and second night. The PSQI-CMU were assessed postoperative first and second night.The primary outcome measure are change of PSQI and PSQI-CMU.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change of interleukin-6 level in plasma samples</measure>
    <time_frame>preoperation and the third postoperative day</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The blood samples were collected before induction of anesthesia and 3 days after the end of surgery.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>3 days after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Postoperative delirium was tested with CAM-ICU 3 days after surgery</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Postoperative Sleep Quality</condition>
  <arm_group>
    <arm_group_label>Target-controlled infusion (Propofol)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>propofol (target plasma concentration of 3 μg/ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhaled anaesthetic (Sevoflurane)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sevoflurane (1.5-2% Minimum Alveolar Concentration)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol (target plasma concentration of 3 μg/ml)</description>
    <arm_group_label>Target-controlled infusion (Propofol)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <description>sevoflurane (1.5-2 Minimum Alveolar Concentration)</description>
    <arm_group_label>Inhaled anaesthetic (Sevoflurane)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants were deemed eligible if they were candidates for spinal anesthesia
             undergoing thyroidectomy

        Exclusion Criteria:

          -  Existing cognitive impairment as evidenced by Mini-Mental State Examination scores
             below 24 (of the 30 possible points)

          -  A history of neurological and psychiatric diseases including stroke, and psychosis

          -  Severe visual or hearing impairment

          -  Unwillingness to comply with the protocol or procedures
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Ma, M.D.,Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>the Anesthesiology Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wen-fei Tan, M.D.,Ph.D.</last_name>
    <phone>86-024-83283100</phone>
    <email>winfieldtan@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>the First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wen-fei Tan, M.D.,Ph.D.</last_name>
      <phone>86-024-83283100</phone>
      <email>winfieldtan@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 23, 2014</lastchanged_date>
  <firstreceived_date>May 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University, China</investigator_affiliation>
    <investigator_full_name>Wen-fei Tan</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>postoperative</keyword>
  <keyword>sleep quality</keyword>
  <keyword>propofol</keyword>
  <keyword>sevoflurane</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
